Advertisement

Topics

Isto and Arteriocyte join forces to form leading biologics player, Isto Biologics

09:41 EDT 19 Oct 2016 | PR Newswire
This article has expired, however you can still download the PDF.
Preview:
ST. LOUIS, Oct. 19, 2016 /PRNewswire/ -- Isto Holdings, the parent company of St. Louis-based Isto Technologies – a leader in bone-regeneration technologies and cell-based therapy – has acquired medical-device company Arteriocyte Medical Systems I...

Other Sources for this Article

NEXT ARTICLE

More From BioPortfolio on "Isto and Arteriocyte join forces to form leading biologics player, Isto Biologics"

Quick Search
Advertisement
 

Relevant Topics

Osteoporosis
Osteoporosis is a disease in which the bones become extremely porous, are subject to fracture, and heal slowly, occurring especially in women following menopause and often leading to curvature of the spine from vertebral collapse. Follow and track&n...

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...